FI841077A0 - Foerfarande foer framstaellning av 2-(2-indenyl) imidazolinderivat - Google Patents

Foerfarande foer framstaellning av 2-(2-indenyl) imidazolinderivat

Info

Publication number
FI841077A0
FI841077A0 FI841077A FI841077A FI841077A0 FI 841077 A0 FI841077 A0 FI 841077A0 FI 841077 A FI841077 A FI 841077A FI 841077 A FI841077 A FI 841077A FI 841077 A0 FI841077 A0 FI 841077A0
Authority
FI
Finland
Prior art keywords
framstation
indenyl
procedure
imidazole derivatives
imidazole
Prior art date
Application number
FI841077A
Other languages
English (en)
Other versions
FI841077A (fi
Inventor
Dennis Bigg
Jacques Menin
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI841077A0 publication Critical patent/FI841077A0/fi
Publication of FI841077A publication Critical patent/FI841077A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI841077A 1983-03-18 1984-03-16 Foerfarande foer framstaellning av 2-(2- indenyl)imidazolinderivat. FI841077A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8304524A FR2542738A1 (fr) 1983-03-18 1983-03-18 Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
FI841077A0 true FI841077A0 (fi) 1984-03-16
FI841077A FI841077A (fi) 1984-09-19

Family

ID=9287026

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841077A FI841077A (fi) 1983-03-18 1984-03-16 Foerfarande foer framstaellning av 2-(2- indenyl)imidazolinderivat.

Country Status (16)

Country Link
US (1) US4559356A (fi)
EP (1) EP0125937A2 (fi)
JP (1) JPS59186962A (fi)
AU (1) AU559177B2 (fi)
CA (1) CA1217776A (fi)
DK (1) DK112884A (fi)
ES (1) ES530681A0 (fi)
FI (1) FI841077A (fi)
FR (1) FR2542738A1 (fi)
GR (1) GR81885B (fi)
HU (1) HU191597B (fi)
IL (1) IL71270A0 (fi)
NO (1) NO841021L (fi)
NZ (1) NZ207524A (fi)
PT (1) PT78272B (fi)
ZA (1) ZA841985B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583900D1 (de) * 1984-06-06 1991-10-02 Abbott Lab Adrenergische verbindungen.
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FR2787451B1 (fr) * 1998-12-18 2001-01-26 Adir Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU778522B2 (en) * 1999-10-29 2004-12-09 Orion Corporation Treatment or prevention of hypotension and shock

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731471A (en) * 1956-01-17 Nxg hi
US2842478A (en) * 1955-08-25 1958-07-08 Pfizer & Co C Tetrahydrozoline-central nervous system depressant veterinary compositions and method of using same
US3287469A (en) * 1963-09-27 1966-11-22 Du Pont Naphthyl-and indanylimidazolines

Also Published As

Publication number Publication date
FI841077A (fi) 1984-09-19
GR81885B (fi) 1984-12-12
NO841021L (no) 1984-09-19
HU191597B (en) 1987-03-30
AU559177B2 (en) 1987-02-26
PT78272A (fr) 1984-04-01
CA1217776A (en) 1987-02-10
DK112884A (da) 1984-09-19
US4559356A (en) 1985-12-17
ES8500907A1 (es) 1984-11-01
FR2542738A1 (fr) 1984-09-21
DK112884D0 (da) 1984-02-28
AU2581984A (en) 1984-09-20
PT78272B (fr) 1986-08-08
ZA841985B (en) 1984-10-31
EP0125937A2 (fr) 1984-11-21
HUT34165A (en) 1985-02-28
ES530681A0 (es) 1984-11-01
IL71270A0 (en) 1984-06-29
JPS59186962A (ja) 1984-10-23
NZ207524A (en) 1986-07-11

Similar Documents

Publication Publication Date Title
ES504257A0 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos
NO844879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater
NO841158L (no) Fremgangsmaate for fremstilling av 2-azetidin-4-substituerte forbindelser
ES537718A0 (es) Procedimiento de preparacion de nuevas sales de derivados organofosforados
NO844978L (no) Fremgangsmaate ved fremstilling av nye aminoguanidinderivater
NO844118L (no) Fremgangsmaate for fremstilling av imidazolinderivater
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
FI833648A0 (fi) Foerfarande foer framstaellning av 4-metyl-5-alkyltiometylimidazoler
FI841077A0 (fi) Foerfarande foer framstaellning av 2-(2-indenyl) imidazolinderivat
FI824216A0 (fi) Foerfarande foer framstaellning av (-)-2-/1-(2,6-diklorfenoxi)-etyl-/1,3-diazacyklopent-2-en
NO844090L (no) Fremgangsmaate for fremstilling av 2-azacykloalkyltio-2-penem-3-karboksylsyre-derivater
NO831994L (no) Fremgangsmaate for fremstilling av pyrimidinon-derivater
ES536969A0 (es) Procedimiento para la preparacion de nuevos derivados de 1-(acetilaminofenil)-2-amino-propanona
NO831874L (no) Fremgangsmaate for fremstilling av trifenylbuten-derivater
NO169575C (no) Fremgangsmaate for fremstilling av en galenisk form av sulpirid
ES529823A0 (es) Un procedimiento de preparacion de derivados de hidantoina
NO820048L (no) Fremgangsmaate for fremstilling av 3-pikolin
NO170278C (no) Analogifremgangsmaate for fremstilling av nye antimykotiskvirksomme 2-(tioalkylamino)etyl-1h-imidazolderivater
ES530042A0 (es) Procedimiento para la obtencion de derivados de imidazol conteniendo azufre
AR240826A1 (es) Procedimiento para preparar derivados de 7beta-(2-(2-aminotiazol-4-il)2-alcoxiiminoacetamido)-3-(1-piridinometil)-3-cefem-4-carboxilato
NO844943L (no) Fremgangsmaate for fremstilling av pyrrolo-indolderivater
NO841485L (no) Fremgangsmaate for fremstilling av substituerte difenylazometinderivater
DK175986D0 (da) Substituerede 2-(n-alkynyl-n-phenylamino)imidazolin-derivater
NO844466L (no) Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater
NO844183L (no) Fremgangsmaate til fremstilling av bis-dioksopiperazinderivater

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: SYNTHELABO